Oxford BioMedica (GB:OXB) has released an update.
Oxford Biomedica plc has disclosed its total voting rights with 105,323,963 ordinary shares, indicating no treasury-held shares as of July 31, 2024. This information is crucial for shareholders to assess their notification requirements for shareholding changes under the FCA’s rules. The company, a pioneer in cell and gene therapy, offers extensive viral vector development and manufacturing services to its global pharmaceutical and biotech partners.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
